Amir Lahav

Amir Lahav is currently the Founder and CEO of SkyMedAI, a healthcare AI consulting boutique dedicated to enhancing healthcare through innovative technology and remote patient monitoring. In addition to this role, Amir serves on the External Advisory Board of the B2AI-Voice Consortium, focusing on the ethical advancement of AI voice technologies. Amir holds a position as a Digital Health Advisor at Analog Devices and is an Advisory Board Member for several companies, including Lapsi Health, Blue Spark Technologies, Modality.AI, Videra Health, and ZEPHYRx. Furthermore, Amir collaborates with Mitsubishi Tanabe Pharma America as a Strategic Business Advisor, driving digital healthcare innovation strategies. Educationally, Amir completed a Postdoctoral Fellowship in Neurology at Harvard Medical School and earned a Doctor of Science in Health and Rehabilitation Sciences from Boston University.